| ²é¿´: 1633 | »Ø¸´: 9 | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß runner_stu µÄ 2 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
[½»Á÷]
ÎÄÕ¼øÉÍ£ºUfSP2µ÷¿ØDNAËðÉËÐÞ¸´µÄ»úÖÆ
|
|||
|
ÎÄÕ¼øÉÍ£ºDynamic recruitment of UFM1-specific peptidase 2 to the DNA double-strand breaks regulated by WIP1 ÈËÌåϸ°ûÿÌìÔâÊܵÄDNAËðÉ˸ߴï100000´ÎÒÔÉÏ£¬Ó°ÏìÒòËØ°üÀ¨ÄÚÔ´ÐÔÒòËØ£¨±ÈÈçÈËÌå´úлÎïÑõ»¯×ÔÓÉ»ù£©ºÍÍâÔ´ÐԴ̼¤£¨×ÏÍâÏßÕÕÉä¡¢µçÀë·øÉä¡¢»·¾³ÎÛȾ¼°»¯Ñ§¶¾ËØ£©¡£DNAË«Á´¶ÏÁÑ£¨DSB£©ÊÇ×îÖÂÃüµÄDNAËðÉËÀàÐÍ£¬Ò»µ©·¢ÉúDSB£¬¶¥¶Ë¼¤Ã¸ATM½«¿ìËÙ¼¤»î²¢Ñ¸ËÙÆô¶¯DNAËðÉË·´Ó¦ÐźÅ[1-2]¡£ ATM¼¤»îÊܵ½¶àÖÖ·ÒëºóÐÞÊεĹ²Í¬µ÷½Ú£¬Èç·ºËØ»¯¡¢Á×Ëữ¡¢ÒÒõ£»¯ºÍ¼×»ù»¯µÈµÈ¡£UFMõ£»¯Á¬½ÓøUFM1ÌØÒìÐÔëÄø2£¨UfSP2£©ÊÇÒ»ÀàÈ¥³ýUFM1õ£»¯µÄø£¬´ËǰÒÑÓб¨µÀUfSP2Äܹ»ÒÖÖÆATM¼¤»î£¬µ«UfSP2ÈçºÎµ÷½ÚDNAËðÉË·´Ó¦µÄ»úÖÆÈÔδÇå³þ[3-4]¡£À´×ÔÃÀ¹ú÷°ÂҽѧÖÐÐĵÄÂ¥ÕñÀ¤ÍŶӽüÆÚÔÚSample Text ÔÓÖ¾ÉÏ·¢±íÁËÌâΪ¡°Dynamic recruitment of UFM1-specific peptidase 2 to the DNA double-strand breaks regulated by WIP1 ¡±µÄÑо¿ÂÛÎÄ£¬½ÒʾÁËUfSP2ÈçºÎ¾«È·µ÷¿ØATMͨ·½ø¶øÓ°ÏìDNAËðÉËÐÞ¸´½ø³Ì¡£ [swf]https://641331.freep.cn/641331/fig%201.png[/swf] Fig. 1 UfSP2 suppresses ATM activation. ×÷ÕßÊ×ÏÈÓÃUfSP2ÇóýµÄ293Tϸ°ûת¼»ØÒ°ÉúÐ͵ÄUfSP2»ò²»´øÈ¥¼×õ£Ã¸»îÐÔµÄUfSP2£¬·øÉäÌõ¼þϼì²âÁËATM±í´ï¼°ÆäÁ×Ëữˮƽ£¬ÑéÖ¤ÁËUfSP2È¥Á×ËữH4²¢ÒÖÖÆATM¼¤»î£¨Fig. 1£© [swf]https://641331.freep.cn/641331/fig%202.png[/swf] Fig. 2 Recruitment of UfSP2 to DSB is later than UFL1 recruitment following IR. ÀûÓÃÃâÒß¹²Ó«¹âµÄ·½·¨, ×÷Õß¼ì²âÁËUFL1ºÍUfSP2µÄ¶¯Ì¬·Ö²¼£¬½á¹ûÏÔʾ£¬ºÍUFL1Ïà±È£¬UfSP2ÒÔ½ÏÂýµÄ¶¯Á¦Ñ§ÕÐļµ½DSB£¬²¢ÔÚDSB´¦È¥³ýUFM1 (Fig. 2)¡£µ«UfSP2ÈçºÎ±»ÕÐļµ½DSB£¬ÈÔÊÇδ֪£¬Òò´Ë×÷ÕßɸѡÁËDNAËðÉË·´Ó¦ÖеÄDZÔÚÏ໥×÷Óõ°°×£¬·¢ÏÖUfSP2¿ÉÒÔÓëMre11Ï໥×÷Óã¨Fig. 3a£©¡£Í¨¹ý¶¯Ì¬¼à²â£¬ËûÃÇ·¢ÏÖUfSP2ÔÚIRºóÁ¢¼´´ÓMRN½âÀ룬µ±ATM¼¤»î¹ý³ÌÍê³Éʱ£¬ÆäÓëMRN¸´ºÏÎïµÄÏ໥×÷ÓÃÔÚIRºó2СʱÔòÖð½¥»Ö¸´£¨Fig. 3a£©£¬ MRE11µÄȱʧÔò»áÓ°ÏìUfSP2²¡ÔîµÄÐγɣ¨Fig. 3b£¬c£©£¬ÕâЩ½á¹û±íÃ÷£¬UfSP2ÊÇÓÉMRN¸´ºÏÌåÕÐļµ½DNAË«Á´¶ÏÁѲ¿Î»µÄ¡£ [swf]https://641331.freep.cn/641331/fig%202.png[/swf] Fig. 3 The interaction of UfSP2 with the MRN complex is regulated by ATM-mediated phosphorylation. ATMÊÇDSBÓÕµ¼µÄDNAËðÉË·´Ó¦ÖÐÖØÒªµÄÉÏÓμ¤Ã¸£¬Í¨¹ý·ÖÎöUfSP2µÄµ°°×ÖÊÐòÁкÍWB·½·¨£¬×÷Õß·¢ÏÖATMµ÷½ÚUfSP2µÄÁ×Ëữ²¢Ó°ÏìÆäÓëMRNµÄ½áºÏ£¬Í¨¹ýÃâÒß¹²³ÁµíµÄ·½·¨£¬È·¶¨ÁËUfSP2µÄÈ¥Á×ËữÊܵ½Wip1µ÷¿Ø£¨Fig. 4£©¡£ [swf]https://641331.freep.cn/641331/fig%204.png[/swf] Fig. 4 The phosphatase WIP1 removes phospho-group from UfSP2 induced by ATM. DNAË«Á´¶ÏÁѵÄËðÉËÐÞ¸´»úÖÆÒÑÓдóÁ¿µÄ±¨µÀ£¬ ATMÊÇÒÑÖªµÄ×îΪ¹Ø¼üµÄÉÏÓμ¤Ã¸¡£±¾ÎÄ×÷Õßͨ¹ýһϵÁеÄʵÑ飬Ìá³öÁËUfSP2¶ÔATM¼¤»îµÄ΢Ãµ÷ÖÆ»úÖÆ£ºÕý³£Çé¿öÏ£¬UfSP2ÓëMRN¸´ºÏÎï½áºÏ£¬Ò»µ©·¢ÉúDSB£¬ATMѸËÙ¼¤»î²¢ÓÕµ¼UfSP2Á×Ëữ£¬µ¼ÖÂUfSP2´ÓMRN¸´ºÏÎïÍÑÂ䣬DNAËðÉËÐÞ¸´³ÌÐòÆô¶¯£»µ±ATM¼¤»î¹ý³ÌÍê³Éʱ£¬UfSP2ÔÚWip1µ÷¿ØÏÂÈ¥Á×Ëữ£¬²¢ÔÚMRNÕÐļÏ»ºÂýÖØÐ½áºÏµ½DSB²¿Î»£¬ÒÖÖÆATMµÄ¹ý¶È¼¤»îÒÔ·Àֹϸ°ûµòÍö£¬´Ó¶ø±£Ö¤ÁËϸ°û¼ÈÄÜ¿ìËÙÐÞ¸´DNAË«Á´¶ÏÁÑÓÖ²»»á·¢Éú¹ý¶ÈÐÞ¸´¡£¸Ã·¢ÏÖÊ״βûÃ÷ÁËUfSP2²ÎÓëDSBÐÞ¸´µÄ×÷ÓûúÖÆ£¬¶ÔATMͨ·×ö³öÁËÖØÒªµÄÐÞÕý¡£ ÎÄÕÂͨѶ×÷ÕßÂ¥ÕñÀ¤½ÌÊÚÀ´×ÔÃÀ¹úµÄ÷°ÂҽѧÖÐÐÄ£¬³¤ÆÚÖÂÁ¦ÓÚDNAËðÉËÐÞ¸´Ñо¿£¨³¤°´Ï·½Í¼Æ¬É¨Âë¿É·ÃÎÊ×÷ÕßÖ÷Ò³£©¡£ [swf]https://641331.freep.cn/641331/fig%205.jpg[/swf] ¹ØÓÚGenome Instability & Disease£º Genome Instability & Disease £¨GIAD£©ÊÇÉîÛÚ´óѧҽѧ²¿ÓëÒâ´óÀûÃ×À¼·Ö×ÓÖ×ÁöÑо¿Ëù (IFOM) µÄÓ¢ÎĹٷ½³ö°æÎÓÉSpringer Nature ¼¯Íųö°æ ( ISSN: 2524-7662 ) ¡£ÔÓÖ¾Ö÷Òª·¢±í»ùÒò×éÎȶ¨ÐÔά³Ö»úÖÆ¼°ÆäÏà¹ØÈËÀ༲²¡µÄ·Ö×Ó»úÖÆºÍÖÎÁÆÓ¦ÓõĸßÖÊÁ¿¡¢Í¬ÐÐÆÀÉóµÄÔ´´Ñо¿ÂÛÎÄ¡¢×ÛÊö¡¢¼ò¶ÌͨÐÅ¡¢ÊµÑé·½°¸ºÍÆÀÂÛÎÄÕ¡£ÆÚ¿¯Ä¿Ç°¹²Óбàί51Ãû£¬°üÀ¨5ÃûԺʿºÍ5Ãû»áÊ¿£¬19Ãû¹ú¼Ê±àί£¬¾ùÀ´×ÔDNAËðÉËÐÞ¸´ÁìÓòµÄÖªÃû¿ÆÑ§¼Ò¡£Ö÷±àÊÇÉîÛÚ´óѧµÄÖìÎÀ¹ú½ÌÊÚºÍÒâ´óÀûIFOMµÄMarco Foiani½ÌÊÚ¡£ ×Ô2020ÄêÕýʽ´´¿¯ÒÔÀ´£¬GIADÒÑÁ¬Ðø³ö°æ18ÆÚ£¬Æ½¾ùƪÏÂÔØÁ¿³¬¹ý1200´Î£¬±»CNKI¡¢Google Scholar µÈ¶à¸öÊý¾Ý¿âÊÕ¼£¬²¿·ÖÎÄÕÂÒѱ»PubMedºÍSCIÊÕ¼¡£ [swf]https://641331.freep.cn/641331/%E5%8C%BB%E5%AD%A6%E9%83%A8%E7%A7%91%E7%A0%94%E5%8A%9E%20%E5%AF%B9%E6%8A%98%E9%A1%B5%20a3%20250%E9%93%9C%E7%89%88%E7%BA%B8%E5%8F%8C%E9%9D%A2%E5%BD%A9%E8%89%B2%20%E5%8E%8B%E7%97%95%E5%AF%B9%E6%8A%98%20100%E4%BB%BD_%E9%A1%B5%E9%9D%A2_2.jpg[/swf] ÆÚ¿¯±àίÍÅ¶Ó https://641331.freep.cn/641331/% ... 1%B5%E9%9D%A2_1.jpg ÆÚ¿¯Òѱ»ÊÕ¼µÄÊý¾Ý¿â [swf]https://641331.freep.cn/641331/7326471523911432953-115.jpg[/swf] ×÷Ϊп¯£¬²¿·ÖÎÄÕÂÒѱ»PubmedÊÕ¼ Genome Instability & Disease Ö÷Òª·¢±íÒÔÏÂÁìÓòµÄÎÄÕ£º Topics may include, but are not limited to: Ø Cell cycle checkpoints Ø DNA damage response Ø Post-translational modifications Ø Epigenetic regulation Ø Radio/chemotherapeutic sensitization Ø Genome stability genes as a therapeutic target Ø Genome instability-associated diseases Ø Neurodegenerative diseases Ø DNA damage-based therapy and drug discovery ²Î¿¼ÎÄÏ×£º 1. Lavin, M. F. (2008). Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer. Nature Reviews Molecular Cell Biology, 9, 759¨C769. 2. Lee, J. H., & Paull, T. T. (2004). Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science, 304, 93¨C96. 3. Qin, B., Yu, J., Nowsheen, S., Wang, M., Tu, X., Liu, T., Li, H., Wang, L., & Lou, Z. (2019). UFL1 promotes histone H4 ufmylation and ATM activation. Nature Communications, 10, 1242. 4. Wang, Z., Gong, Y., Peng, B., Shi, R., Fan, D., Zhao, H., Zhu, M., Zhang, H., Lou, Z., Zhou, J., Zhu, W. G., Cong, Y. S., & Xu, X. (2019). MRE11 UFMylation promotes ATM activation. Nucleic Acids Research, 47, 4124¨C4135. |
» ²ÂÄãϲ»¶
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ14È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ18È˻ظ´
½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã
ÒѾÓÐ15È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ7È˻ظ´
ÅóÓÑȦ¿´µ½µÄ
ÒѾÓÐ9È˻ظ´
ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡
ÒѾÓÐ16È˻ظ´
·Å°ñǰµÄ²»µ¶¨
ÒѾÓÐ17È˻ظ´
¿ÆÑй¶ùÌ«ÄÑÁË
ÒѾÓÐ19È˻ظ´
Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿
ÒѾÓÐ4È˻ظ´
ʲôʱºò¿ª½±£¿
ÒѾÓÐ11È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¸æ±ðÁ÷Ë®ÏßˬÎÄ£¡108Íò×ÖÍê½áÏÉÏÀ¡¶Å®æ´Ê¯Ö®ÁéÊ¯ÆæÔµ£¨ÏÉ½çÆª£©¡·ÖµµÃϸƷ
+1/8815
É¢½ðÆí¸£
+5/2975
Сľ³æÈÏʶµÄÀϹ«ÔÚÒ»Æð11Ä꣬ȥÊÀ¿ì100ÌìÁË¡£
+2/2000
»ù½ðÆí¸£
+1/756
ÿÄêÕâʱºòÎÒ¶¼ÔÙ×Ðϸ¶ÁÒ»±é¡¶·¶½øÖо١·
+1/275
ºÎ²»Ê³ÈâÃÓ
+1/270
É¢½ðÆí¸£
+3/195
É¢½ðÆí¸£
+5/65
Î人£¬³ÏÕ÷ÄÐÓÑ£¬²»ÒìµØ£¬ÄêÁä´óÁË
+1/48
°²»ÕÒ½¿Æ´óѧÖܿɳɽÌÊÚ¿ÎÌâ×é³ÏƸ²©Ê¿ºó 2026Äê
+1/18
°²»ÕÒ½¿Æ´óѧÖܿɳɽÌÊÚ¿ÎÌâ×é³ÏƸ²©Ê¿ºó 2026Äê
+1/17
ÄϾ©´óѧ ÖÇÄÜÇý¶¯Óë¸ÐÖª²ÄÁÏʵÑéÊÒ ³ÏÕÐÉêÇ뿼ºË²©Ê¿Éú/¿ÆÑÐÖúÀí/²©Ê¿ºó
+1/4
ÄÏ·½Ò½¿Æ´óѧÉîÛÚÒ½Ôº³ÂìÇ/ÓàÌνÌÊÚ¿ÎÌâ×éÁªºÏÅàÑø²©Ê¿ºóÕÐÆ¸
+1/4
ÖпÆÔº´óÁ¬»¯Ñ§ÎïÀíÑо¿Ëù ÕÐÆ¸ ´ß»¯¼ÁÑз¢·½Ïò ¿ÆÑÐÖúÀí 2Ãû
+1/4
Æíµ»ÀϹ«Öйú»ù
+1/3
ÉϺ£´óѧÍõÁÁ¿ÎÌâ×é³ÏÕв©Ê¿ºó£¨Ì¼²ÄÁÏ¡¢¹â´ß»¯¡¢µç´ß»¯·½Ïò£©
+2/2
ÐÂÉó²éÖ¸ÄÏÊ©ÐаëÄ꣬AI·½ÏòµÄרÀûÉêÇëÊDz»ÊǸü¿´"¼¼Êõζ"ÁË£¿
+1/2
³öȫвÌ˾ Plan?APOCHROMAT 20¡Á/0.8 ƽ³¡¸´ÏûÉ«²îÎï¾µ
+1/2
»ªÎ÷ÉúÎïÖÆÒ©Ñо¿ÔºÕÐÆ¸¿ÆÑÐÖúÀí
+2/2
¡¾²úÆ·²âÆÀ·ÖÏí¡¿ÌåÍâת¼²úÁ¿²»ÀíÏë¡¢dsRNA ¸±²úÎï¸ß£¿T7 RNA ¾ÛºÏøʵ²âÌåÑé
+1/1
chenhuanlong
½û³æ (ÎÄѧ̩¶·)
¡ï
runner_stu(½ð±Ò+1): лл²ÎÓë
runner_stu(½ð±Ò+1): лл²ÎÓë
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
5Â¥2023-01-04 19:00:05
10Â¥2024-11-17 19:49:20
¼òµ¥»Ø¸´
tzynew2Â¥
2023-01-04 16:31
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
o ·¢×ÔСľ³æAndroid¿Í»§¶Ë
GZ8509053Â¥
2023-01-04 16:32
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
nono20094Â¥
2023-01-04 17:00
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
`
yuekong6Â¥
2023-01-04 19:10
»Ø¸´
bush2867Â¥
2023-01-04 20:48
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
XG-WUST8Â¥
2023-01-05 07:00
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
up ·¢×ÔСľ³æIOS¿Í»§¶Ë
xiaoqiuqiu209Â¥
2023-01-05 22:03
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë









»Ø¸´´ËÂ¥